BREAKPOINTS FOR ENTEROBACTERIACEAE

Patient name Sample #

ISOLATE DATE

Result S I R Notes
Ampicllin ≥17 14-16 ≤13
Ampicillin Sulbactam ≥15 12-14 ≤11
Amoxicillin Clavulnate ≥18 14-17 ≤13
Gentamycin ≥15 13-14 ≤12
Amikacin ≥17 15-16 ≤14
Piperacillin Tazobactam ≥21 18-20 ≤17
Cefazolin ≥23 20-22 ≤19
Cefixime ≥19 16-18 ≤15
Ceftazidime ≥21 18-20 ≤17
Cefruxime ≥23 15-22 ≤14
Cefepime ≥25 19-24 ≤18
Cefotaxime ≥26 23-25 ≤22
Ceftriaxone ≥23 20-22 ≤19
Aztreonem ≥21 18-20 ≤17
Ciprofloxacin ≥26 22-25 ≤21
Imipenem ≥23 20-22 ≤19
Ertapenem ≥22 19-21 ≤18
Trimethoprim sulfa ≥16 11-15 ≤10
Nitrofurantoin ≥17 15-16 ≤14
ESBL
HODGE TEST
SALMONELLA/Shigella
Ciprofloxacin ≥31 21-30 ≤20 Intestinal
Ampicllin ≥17 14-16 ≤13 Intestinal
Trimethoprim sulfa ≥16 11-15 ≤10 Intestinal
** Ceftriaxone ≥23 20-22 ≤19 Extraintestinal
Azithromycin ≥13 ≤12 Extraintestinal/ If requested
Azithromycin ≥16 ≤15 FOR SHIEGELLA